NOV 01, 2017 3:05 PM PDT

Study Uncovers 27 New and Rare Cancer-Fighting Genes

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

A systematic survey of over 2200 tumors has revealed 27 new cancer-fighting genes that could help patients battle the disease and win.

The genetics of cancer is a tangled, complicated mess that invariably involves multiple genes and pathways. But at its most basic core, cancer genetics can be understood in terms of cancer-promoting genes (oncogenes) and cancer-fighting genes (tumor suppressor genes).

Oncogenes are those involved in cell growth and division, proliferation, or the avoidance of cell death. When these genes are mutated or become expressed at abnormally high levels, it allows a cell to grow and divide with reckless abandon – a key hallmark of cancer.

By contrast, tumor suppressor genes act to stop cells from becoming cancerous, as the name implies. These genes are usually involved at critical checkpoints in the cell cycle. Under normal conditions, these genes prevent cells from dividing endlessly and trigger cell death when appropriate. However, when these gatekeeper genes pick up inactivating mutations, cancer can take over.

Unlike oncogenes, tumor suppressor genes generally need mutations on both copies for the gene to go rogue. This “two-hit” hypothesis explains why some tumor suppressor genes can still protect against cancer invasion even when one copy of the gene is deleted.

To search for tumor suppressor genes, researchers from the Francis Crick Institute in the United Kingdom had to develop a new statistical model that can distinguish if one or both copies of a gene has been inactivated in cancer – a challenging feat since tumors contain a mix of genetic profiles that can obscure the hunt.

When tested in over 2200 tumor samples across 12 human cancer types, the team found 96 genetic hotspots for tumor suppressor gene deletion. In these regions, they identified 43 tumor suppressor genes, 27 of which were rare and new.

"Our study demonstrates," said Peter Van Loo, the study’s senior author, "that rare tumor suppressor genes can be identified through large-scale analysis of the number of copies of genes in cancer samples."

"Cancer genomics is a growing area of research, and the computational tools we use are a powerful way to find new genes involved in cancer," he adds.

Researchers hope the new information can be leveraged to find new targets against cancer, one of the most devastating health burdens across the globe. According to National Cancer Institute, over 1.6 million new cases of cancer were diagnosed in 2016. And of that, nearly 600,000 will succumb to the disease. Given such odds, the discovery of new and rare cancer-fighting genes couldn’t have come at a more urgent time.

"Using this powerful toolkit, we've uncovered rare tumor suppressor genes that when lost in mutated cells, cause cancer. This could pave the way for the development of personalized cancer treatments,” said Jonas Demeulemeester, a study co-author.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 14, 2020
Genetics & Genomics
Why Defects in One Gene Can Lead to Cancer in Kids
SEP 14, 2020
Why Defects in One Gene Can Lead to Cancer in Kids
While they may occur in adults, a rare, aggressive type of brain cancer called atypical teratoid rhabdoid tumors tend to ...
SEP 30, 2020
Cancer
Chemokines Could be the Key in Controlling Glioma Stem Cells
SEP 30, 2020
Chemokines Could be the Key in Controlling Glioma Stem Cells
The transformation of a healthy cell into a cancerous one often comes with a slew of cellular signaling changes.  T ...
OCT 06, 2020
Cannabis Sciences
Cannabis Use May Reduce Cancer Risk by 10%
OCT 06, 2020
Cannabis Use May Reduce Cancer Risk by 10%
A recent meta-analysis of 34 studies found that cannabis use may decrease one’s risk of developing certain kinds o ...
OCT 28, 2020
Cancer
Race disparities still exist among patients with lung cancer
OCT 28, 2020
Race disparities still exist among patients with lung cancer
Research published recently in the Journal of Surgical Oncology looks at the disparities in lung cancer treatment a ...
NOV 06, 2020
Drug Discovery & Development
Anti-depressant Shows Promise in Treating Childhood Cancer
NOV 06, 2020
Anti-depressant Shows Promise in Treating Childhood Cancer
Researchers from Sweden and the US have found that a commonly prescribed antidepressant may help stop the growth of a ca ...
NOV 14, 2020
Cancer
New intravenous anti-cancer therapy crosses blood-brain barrier
NOV 14, 2020
New intravenous anti-cancer therapy crosses blood-brain barrier
New research from the University of Michigan reports for the first time a new synthetic protein nanoparticle that is abl ...
Loading Comments...